Management of acute promyelocytic leukemia: updated recommendations from an expert panel of the European LeukemiaNet von Sanz, Miguel A., Fenaux, Pierre, Tallman, Martin S., Estey, Elihu H., Löwenberg, Bob, Naoe, Tomoki, Lengfelder, Eva, Döhner, Hartmut, Burnett, Alan K., Chen, Sai-Juan, Mathews, Vikram, Iland, Harry, Rego, Eduardo, Kantarjian, Hagop, Adès, Lionel, Avvisati, Giuseppe, Montesinos, Pau, Platzbecker, Uwe, Ravandi, Farhad, Russell, Nigel H., Lo-Coco, Francesco

Volltext

Refinement of cytogenetic classification in acute myeloid leukemia: determination of prognostic significance of rare recurring chromosomal abnormalities among 5876 younger adult pa... von Grimwade, David, Hills, Robert K., Moorman, Anthony V., Walker, Helen, Chatters, Stephen, Goldstone, Anthony H., Wheatley, Keith, Harrison, Christine J., Burnett, Alan K.

Volltext

Arsenic trioxide and all- trans retinoic acid treatment for acute promyelocytic leukaemia in all risk groups (AML17): results of a randomised, controlled, phase 3 trial von Burnett, Alan K, Prof, Russell, Nigel H, Prof, Hills, Robert K, DPhil, Bowen, David, Prof, Kell, Jonathan, MD, Knapper, Steve, DM, Morgan, Yvonne G, PhD, Lok, Jennie, MSc, Grech, Angela, BA, Jones, Gail, MD, Khwaja, Asim, Prof, Friis, Lone, PhD, McMullin, Mary Frances, Prof, Hunter, Ann, MD, Clark, Richard E, Prof, Grimwade, David, Prof

Volltext

Assessment of Minimal Residual Disease in Standard-Risk AML von Ivey, Adam, Hills, Robert K, Simpson, Michael A, Jovanovic, Jelena V, Gilkes, Amanda, Grech, Angela, Patel, Yashma, Bhudia, Neesa, Farah, Hassan, Mason, Joanne, Wall, Kerry, Akiki, Susanna, Griffiths, Michael, Solomon, Ellen, McCaughan, Frank, Linch, David C, Gale, Rosemary E, Vyas, Paresh, Freeman, Sylvie D, Russell, Nigel, Burnett, Alan K, Grimwade, David

Volltext

Addition of gemtuzumab ozogamicin to induction chemotherapy in adult patients with acute myeloid leukaemia: a meta-analysis of individual patient data from randomised controlled tr... von Hills, Robert K, DPhil, Castaigne, Sylvie, Prof, Appelbaum, Frederick R, Prof, Delaunay, Jacques, MD, Petersdorf, Stephen, MD, Othus, Megan, PhD, Estey, Elihu H, Prof, Dombret, Hervé, Prof, Chevret, Sylvie, PhD, Ifrah, Norbert, Prof, Cahn, Jean-Yves, Prof, Récher, Christian, Prof, Chilton, Lucy, PhD, Moorman, Anthony V, Prof, Burnett, Alan K, Prof

Volltext

Unified classification and risk-stratification in Acute Myeloid Leukemia von Tazi, Yanis, Arango-Ossa, Juan E., Zhou, Yangyu, Bernard, Elsa, Thomas, Ian, Gilkes, Amanda, Freeman, Sylvie, Pradat, Yoann, Johnson, Sean J., Hills, Robert, Dillon, Richard, Levine, Max F., Leongamornlert, Daniel, Butler, Adam, Ganser, Arnold, Bullinger, Lars, Döhner, Konstanze, Ottmann, Oliver, Adams, Richard, Döhner, Hartmut, Campbell, Peter J., Burnett, Alan K., Dennis, Michael, Russell, Nigel H., Devlin, Sean M., Huntly, Brian J. P., Papaemmanuil, Elli

Volltext

Prognostic Relevance of Treatment Response Measured by Flow Cytometric Residual Disease Detection in Older Patients With Acute Myeloid Leukemia von FREEMAN, Sylvie D, VIRGO, Paul, COUZENS, Steve, GRIMWADE, David, RUSSELL, Nigel, HILLS, Robert K, BURNETT, Alan K

Volltext

Measurable Residual Disease at Induction Redefines Partial Response in Acute Myeloid Leukemia and Stratifies Outcomes in Patients at Standard Risk Without NPM1 Mutations von Freeman, Sylvie D, Hills, Robert K, Virgo, Paul, Khan, Naeem, Couzens, Steve, Dillon, Richard, Gilkes, Amanda, Upton, Laura, Nielsen, Ove Juul, Cavenagh, James D, Jones, Gail, Khwaja, Asim, Cahalin, Paul, Thomas, Ian, Grimwade, David, Burnett, Alan K, Russell, Nigel H

Volltext

Minimal residual disease monitoring by quantitative RT-PCR in core binding factor AML allows risk stratification and predicts relapse: results of the United Kingdom MRC AML-15 tria... von Yin, John A. Liu, O'Brien, Michelle A., Hills, Robert K., Daly, Sarah B., Wheatley, Keith, Burnett, Alan K.

Volltext

Optimization of Chemotherapy for Younger Patients With Acute Myeloid Leukemia: Results of the Medical Research Council AML15 Trial von BURNETT, Alan K, RUSSELL, Nigel H, HILLS, Robert K, HUNTER, Ann E, KJELDSEN, Lars, YIN, John, GIBSON, Brenda E. S, WHEATLEY, Keith, MILLIGAN, Donald

Volltext

Addition of Gemtuzumab Ozogamicin to Induction Chemotherapy Improves Survival in Older Patients With Acute Myeloid Leukemia von BURNETT, Alan K, RUSSELL, Nigel H, WHEATLEY, Keith, MILLIGAN, Donald, HILLS, Robert K, KELL, Jonathan, FREEMAN, Sylvie, KJELDSEN, Lars, HUNTER, Ann E, YIN, John, CRADDOCK, Charles F, HOEGH DUFVA, Inge

Volltext

Identification of Patients With Acute Myeloblastic Leukemia Who Benefit From the Addition of Gemtuzumab Ozogamicin: Results of the MRC AML15 Trial von BURNETT, Alan K, HILLS, Robert K, MILLIGAN, Donald, KJELDSEN, Lars, KELL, Jonathan, RUSSELL, Nigel H, YIN, John A. L, HUNTER, Ann, GOLDSTONE, Anthony H, WHEATLEY, Keith

Volltext

Curability of Patients With Acute Myeloid Leukemia Who Did Not Undergo Transplantation in First Remission von BURNETT, Alan K, GOLDSTONE, Anthony, HILLS, Robert K, MILLIGAN, Donald, PRENTICE, Archie, YIN, John, WHEATLEY, Keith, HUNTER, Ann, RUSSELL, Nigel

Volltext

Diagnosis and management of acute myeloid leukemia in adults: recommendations from an international expert panel, on behalf of the European LeukemiaNet von Döhner, Hartmut, Estey, Elihu H., Amadori, Sergio, Appelbaum, Frederick R., Büchner, Thomas, Burnett, Alan K., Dombret, Hervé, Fenaux, Pierre, Grimwade, David, Larson, Richard A., Lo-Coco, Francesco, Naoe, Tomoki, Niederwieser, Dietger, Ossenkoppele, Gert J., Sanz, Miguel A., Sierra, Jorge, Tallman, Martin S., Löwenberg, Bob, Bloomfield, Clara D.

Volltext

Management of acute promyelocytic leukemia: recommendations from an expert panel on behalf of the European LeukemiaNet von Sanz, Miguel A., Grimwade, David, Tallman, Martin S., Lowenberg, Bob, Fenaux, Pierre, Estey, Elihu H., Naoe, Tomoki, Lengfelder, Eva, Büchner, Thomas, Döhner, Hartmut, Burnett, Alan K., Lo-Coco, Francesco

Volltext

The prognostic significance of IDH2 mutations in AML depends on the location of the mutation von Green, Claire L., Evans, Catherine M., Zhao, Lu, Hills, Robert K., Burnett, Alan K., Linch, David C., Gale, Rosemary E.

Volltext

Prognostic Significance of CEBPA Mutations in a Large Cohort of Younger Adult Patients With Acute Myeloid Leukemia: Impact of Double CEBPA Mutations and the Interaction With FLT3 a... von GREEN, Claire L, KOO, Kenneth K, HILLS, Robert K, BURNETT, Alan K, LINCH, David C, GALE, Rosemary E

Volltext

Outcomes of older patients aged 60 to 70 years undergoing reduced intensity transplant for acute myeloblastic leukemia: results of the NCRI acute myeloid leukemia 16 trial von Russell, Nigel H, Hills, Robert K, Thomas, Abin, Thomas, Ian, Kjeldsen, Lars, Dennis, Mike, Craddock, Charles, Freeman, Sylvie, Clark, Richard E, Burnett, Alan K

Volltext

Prospective Minimal Residual Disease Monitoring to Predict Relapse of Acute Promyelocytic Leukemia and to Direct Pre-Emptive Arsenic Trioxide Therapy von GRIMWADE, David, JOVANOVIC, Jelena V, RENNIE, Kristian, CLARK, Roger, CLARK, Richard E, SOLOMON, Ellen, LO-COCO, Francesco, WHEATLEY, Keith, BURNETT, Alan K, HILLS, Robert K, NUGENT, Elizabeth A, PATEL, Yashma, FLORA, Rajinder, DIVERIO, Daniela, JONES, Katy, ASLETT, Hannah, BATSON, Elaine

Volltext

Cytogenetics of Childhood Acute Myeloid Leukemia: United Kingdom Medical Research Council Treatment Trials AML 10 and 12 von HARRISON, Christine J, HILLS, Robert K, GIBSON, Brenda E. S, MOORMAN, Anthony V, GRIMWADE, David J, HANN, Ian, WEBB, David K. H, WHEATLEY, Keith, DE GRAAF, Siebold S. N, VAN DEN BERG, Eva, BURNETT, Alan K

Volltext